Found: 14
Select item for more details and to access through your institution.
Receptor Discordance: Does it Mean Anything?
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 419, doi. 10.3816/CBC.2010.n.066
- By:
- Publication type:
- Article
Outcome of Patients With Early Breast Cancer Receiving Nitrogen-Containing Bisphosphonates: A Comparative Analysis From the Metropolitan Detroit Cancer Surveillance System.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 459, doi. 10.3816/CBC.2010.n.060
- By:
- Publication type:
- Article
CLEOPATRA: A Phase III Evaluation of Pertuzumab and Trastuzumab for HER2-Positive Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 489, doi. 10.3816/CBC.2010.n.065
- By:
- Publication type:
- Article
Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Clinical Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 412
- By:
- Publication type:
- Article
Proceedings of the First Global Workshop on Breast Cancer: Pathways to the Evaluation and Clinical Development of Novel Agents for Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 421, doi. 10.3816/CBC.2010.n.056
- By:
- Publication type:
- Article
Phase II Study of Bortezomib and Pegylated Liposomal Doxorubicin in the Treatment of Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 465, doi. 10.3816/CBC.2010.n.061
- By:
- Publication type:
- Article
The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 452, doi. 10.3816/CBC.2010.n.059
- By:
- Publication type:
- Article
Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 440, doi. 10.3816/CBC.2010.n.057
- By:
- Publication type:
- Article
Randomized Trial of Adjuvant Zoledronic Acid in Postmenopausal Women With High-Risk Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 471, doi. 10.3816/CBC.2010.n.062
- By:
- Publication type:
- Article
Selected Phase III Trials in Recurrent/Metastatic Breast Cancer Conducted in the United States.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 492, doi. 10.1016/S1526-8209(11)70200-2
- By:
- Publication type:
- Article
Sentinel Lymph Node Micrometastasis and Risk of Non-Sentinel Lymph Node Metastasis: Validation of Two Breast Cancer Nomograms.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 445
- By:
- Publication type:
- Article
Sentinel Lymph Node Dissection Is Technically Feasible in Older Breast Cancer Patients.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 477, doi. 10.3816/CBC.2010.n.063
- By:
- Publication type:
- Article
Phase II Trial of Combination of Pegylated Liposomal Doxorubicin, Cisplatin, and Infusional 5-Fluorouracil (CCF) Plus Trastuzumab as Preoperative Treatment for Locally Advanced and Inflammatory Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2010, v. 10, n. 6, p. 483, doi. 10.3816/CBC.2010.n.064
- By:
- Publication type:
- Article